Cholangiocarcinoma in cirrhosis: absence of contrast washout in delayed phases by magnetic resonance imaging avoids misdiagnosis of hepatocellular carcinoma
- PMID: 19610049
- DOI: 10.1002/hep.23071
Cholangiocarcinoma in cirrhosis: absence of contrast washout in delayed phases by magnetic resonance imaging avoids misdiagnosis of hepatocellular carcinoma
Abstract
This study assesses the magnetic resonance (MR) features of intrahepatic cholangiocarcinoma (ICC) in patients with cirrhosis with specific analysis of the contrast enhancement pattern. Cholangiocarcinoma may show increased contrast uptake in the arterial phase, and, if washout in the delayed venous phase were to be detected, the noninvasive diagnostic criteria proposed in the American Association for the Study of Liver Diseases guidelines would be refuted. We reviewed the MR findings of 25 patients with cirrhosis with 31 histologically confirmed ICC nodules. Signal intensity on basal T1-weighted and T2-weighted images and characteristics of enhancement after contrast administration on arterial, portal, and delayed phase were registered. Enhancement pattern was defined according to the behavior of the lesions in each phase, and dynamic pattern was described according to the progression of enhancement throughout the different phases. The most frequent pattern displayed by ICC was a progressive contrast uptake (80.6%). Stable contrast enhancement was registered in 19.4%. None of the ICCs showed a washout pattern, a profile that is specific for hepatocellular carcinoma (HCC). The ICC dynamic behavior differed significantly according to tumor size: progressive enhancement pattern was the most frequent (20 of 25 cases) in lesions larger than 20 mm, whereas the stable pattern was mainly identified in nodules smaller than 20 mm. The most characteristic MR contrast pattern in ICC in cirrhosis is a progressive contrast uptake throughout the different phases, whereas contrast washout at delayed phases is not observed. Because stable enhancement pattern without washout also can be registered in small HCC nodules, the evaluation of delayed phase is mandatory for a proper nodule characterization. If washout is not registered, a biopsy should be mandatory for diagnosis.
Comment in
-
Comments on minimizing misdiagnosis of hepatocellular carcinoma from magnetic resonance imaging.Hepatology. 2009 Oct;50(4):1316; author reply 1316-7. doi: 10.1002/hep.23177. Hepatology. 2009. PMID: 19790088 No abstract available.
Similar articles
-
Small hypervascular hepatocellular carcinoma: limited value of portal and delayed phases on dynamic magnetic resonance imaging.Acta Radiol. 2008 Sep;49(7):735-43. doi: 10.1080/02841850802120045. Acta Radiol. 2008. PMID: 18608015
-
Fat-suppressed dynamic and delayed gadolinium-enhanced volumetric interpolated breath-hold magnetic resonance imaging of cholangiocarcinoma.J Comput Assist Tomogr. 2008 Mar-Apr;32(2):178-84. doi: 10.1097/RCT.0b013e31806bef8e. J Comput Assist Tomogr. 2008. PMID: 18379298
-
Mangafodipir trisodium-enhanced MRI for the detection and characterization of focal hepatic lesions: is delayed imaging useful?J Magn Reson Imaging. 2006 May;23(5):706-11. doi: 10.1002/jmri.20557. J Magn Reson Imaging. 2006. PMID: 16565954 Clinical Trial.
-
MR imaging of hepatocellular carcinoma.Magn Reson Imaging Clin N Am. 2000 Nov;8(4):757-68. Magn Reson Imaging Clin N Am. 2000. PMID: 11149678 Review.
-
Magnetic resonance imaging of cholangiocarcinoma.Semin Liver Dis. 2004 May;24(2):155-64. doi: 10.1055/s-2004-828892. Semin Liver Dis. 2004. PMID: 15192788 Review.
Cited by
-
Atypical Manifestation of Primary Hepatocellular Carcinoma and Hepatic Malignancy Mimicking Lesions.J Korean Soc Radiol. 2022 Jul;83(4):808-829. doi: 10.3348/jksr.2021.0178. Epub 2022 May 23. J Korean Soc Radiol. 2022. PMID: 36238905 Free PMC article. Review.
-
Cholangiocarcinoma.Lancet. 2014 Jun 21;383(9935):2168-79. doi: 10.1016/S0140-6736(13)61903-0. Epub 2014 Feb 26. Lancet. 2014. PMID: 24581682 Free PMC article. Review.
-
Value of perfusion parameters histogram analysis of triphasic CT in differentiating intrahepatic mass forming cholangiocarcinoma from hepatocellular carcinoma.Sci Rep. 2021 Nov 30;11(1):23163. doi: 10.1038/s41598-021-02667-4. Sci Rep. 2021. PMID: 34848818 Free PMC article.
-
CT and MR imaging diagnosis and staging of hepatocellular carcinoma: part II. Extracellular agents, hepatobiliary agents, and ancillary imaging features.Radiology. 2014 Oct;273(1):30-50. doi: 10.1148/radiol.14132362. Radiology. 2014. PMID: 25247563 Free PMC article. Review.
-
Imaging of HCC-Current State of the Art.Diagnostics (Basel). 2015 Nov 27;5(4):513-45. doi: 10.3390/diagnostics5040513. Diagnostics (Basel). 2015. PMID: 26854169 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical